The SEC charged Laura Perryman, former Stimwave CEO and co-founder, with defrauding investors out of approximately $41 million. Perryman founded and served as CEO of Florida-based Stimwave until her termination in 2019. In February 2020, Stimwave ceased all sales of its high-frequency spinal cord stimulation systems in exchange for the dismissal of a patent infringement lawsuit brought by […]
Neuromodulation/Neurostimulation
ShiraTronics reports first implants of minimally invasive implant for treating chronic migraine
ShiraTronics announced the successful implantation of its Chronic Migraine System in the world’s first six patients. Minneapolis-based ShiraTronics designed the neuromodulation system to address the debilitating symptoms of migraines. The company says it offers the first-ever fully implantable system for head location utilizing a minimally invasive approach. The fully implantable, programmable device delivers electrical pulses […]
NeuroOne stock is down on Q4 revenue misses
NeuroOne Medical Technologies (Nasdaq:NMTC) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast. Shares of NMTC fell 8.2% at $1.58 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — dipped 0.2%. The Eden Prairie, Minnesota-based company […]
ElectroCore expands nerve stimulation IP portfolio
ElectroCore (Nasdaq:ECOR) announced today that the U.S. Patent and Trademark office (USPTO) issued it a new nerve stimulation patent. The new patent (No. 11,839,764 ) relates to a system for stimulating a nerve target in the head or neck of a patient. It covers the treatment of various disorders, such as primary headache. It’s titled […]
Cognito Therapeutics reports non-invasive neuromod data for treating Alzheimer’s
Cognito Therapeutics today announced the publication of MRI imaging data from a study of its non-invasive neurostimulation technology. The company published MRI imaging data from the Phase 2 OVERTURE study in the Journal of Alzheimer’s Disease. Cambridge, Massachusetts-based Cognito evaluated patients with mild-moderate Alzheimer’s disease receiving one-hour daily treatment. Patients underwent treatment with the Cognito gamma […]
Medtronic wins CE mark for rechargeable deep brain stimulation tech
Medtronic announced that it received CE mark approval for its Percept RC neurostimulation device. The medtech giant labeled the deep brain stimulation (DBS) device as the smallest and thinnest device on the market. Also rechargeable, the system features BrainSense sensing technology. Medtronic says its launch marks the first release of a rechargeable DBS system with […]
5 more brain-computer interface companies you need to know
The brain-computer interface (BCI) space continues to rise in notoriety, and a number of players are throwing their hats in the ring. Such technologies could enable users to control a computer with their brain, or even go beyond that. Countless immobile people someday could control a mouse cursor, keyboard, mobile device/tablet, wheelchair or prosthetic device […]
Boston Scientific closes Relievant Medsystems acquisition
Boston Scientific announced today that it completed its previously announced acquisition of Relievant Medsystems. In September, Boston Scientific announced plans to acquire Relievant for an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for […]
NeuroOne is pursuing drug delivery with neural probes
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it received a patent for drug delivery with neural probe devices. The United States Patent and Trademark Office (USPTO) issued the patent titled “Agent-Delivering Neural Probe Devices and Related Systems and Methods.” It covers novel electrodes that can operate as a standard neural electrode that delivers a treatment […]
NeuroOne picks former Cardiovascular Systems VP as new COO
NeuroOne Medical Technologies (Nasdaq:NMTC) announced that it appointed Christopher R. Volker as its chief operating officer (COO). Volker joins the Eden Prairie, Minnesota-based neurotech company from Abbott. He previously served as VP and GM of international at Cardiovascular Systems (CSI), which Abbott acquired earlier this year. “Chris’ appointment further strengthens our executive leadership team and […]
Stimvia completes enrollment in study of neurostim for Parkinson’s
Stimvia announced today that it completed enrollment in a study of neuromodulation for treating Parkinson’s disease and essential tremor. The study evaluates the Czech Republic-based company’s Uris device, which uses peroneal neuromodulation (eTNM) for deep brain stimulation. The Uris system previously demonstrated high effectiveness in treating overactive bladder. Uris, a non-invasive system, utilizes active closed-loop […]